chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Can't lift his arm that he received the vaccine in; Moving his arm is so painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Can't lift his arm that he received the vaccine in) and VACCINATION SITE PAIN (Moving his arm is so painful) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Can't lift his arm that he received the vaccine in) and VACCINATION SITE PAIN (Moving his arm is so painful). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Can't lift his arm that he received the vaccine in) and VACCINATION SITE PAIN (Moving his arm is so painful) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up 1: Event outcomes were changed from not recovered to recovered.
Paralysis; Patient was crawling instead of walking....Mother brought to Hospital, was admitted to PICU, given I.V. IGE, and not long after receiving fluids (few hours later), he was running around and playing in the room (according to doctor at hospital).
Client developed psoriaform plaques on neck, trunk, back, legs and arms approx 2-3 weeks post vaccination.  No other symptoms.
Major heart attack; He kept getting sick back to back; This is a spontaneous report from a non-contactable consumer. This consumer reported for a male patient (reporter's father) that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient suffered a major heart attack and passed was on 04Jul2021. Ever since the vaccine was given to him, he kept getting sick back to back in 2021. He was never diagnosed with anything before the shot. The outcome of event getting sick back to back was unknown. The outcome of event major heart attack was fatal. The patient died on 04Jul2021. It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: major heart attack
Cough for 16 days after vaccine and on day 16 started burning up that i went outside to cool down.  When I came back in I had a rash all over my torso.  The rash lasted about 1.5 days
This spontaneous report as received from a registered nurse via a company representative refers to a female patient of unknown age.  The patient's medical history, concurrent conditions and concomitant medications were not provided.  On an unspecified date the patient was vaccinated with GARDASIL 9, intramuscular, for prophylaxis (lot# not provided).  The nurse reported that on an unspecified date, "six months ago," the patient experienced fainting and clonic movements immediately after administration of her first dose of GARDASIL 9.  The patient recovered while in the office and did not require medical treatment.  No further information was provided.  The outcome of the events was reported as resolved. Additional information is not expected as the nurse did not consent to follow-up.
ADMINISTRATION ERROR / DEVIATION. VACCINE WAS MIXED WITH TOO LITTLE DILUENT.
This spontaneous report as received from a nurse refers to a 9 months 5 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) liquid PEDVAXHIB (injection, lot # K016965, exp date: 20-JUL-201)(dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
From EMR: Immediate cause of death: acute hypoxemic respiratory failure (2 days from onset to death) Secondary conditions leading to death: pneumonia (2 days from onset to death) COVID-19 (2 weeks) Other conditions present at time of death: coronary artery disease, Parkinson dementia, pulmonary embolism Was smoking a factor: no COD listed as COD listed as CARDIAC ARREST, COVID-19 PNEUMONIA, HYPOXIC ISCHEMIC ENCEPHALOPATHY, ASPIRATION PNEUMONIA   Died of COVID-19 illness on 06/13/2021
Pulse 131, BP 182/102, weak, chest flushed/red, jittery.  This all occurred 15 mins after shot
bronchitis; Initial information received on 20-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer or non health care professional via social media.  This case involves a patient (unknown age) who experienced bronchitis, while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious bronchitis (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.   It was not reported if the patient received any corrective treatment.  At the time of reporting, patient had recovered from the event (last about 4-6 weeks).  There will be no information available on batch number for this case.
pt recv vax & exp flu-like sx which included fever, malaise, h/a, upper resp cough, sweating, & chills;some patients exp joint pain;all patient's were vaccinated w/the same lot#
Patient came into our pharmacy on Wednesday, March 20, 2019 to show the pharmacist (me)  several spots only on  her right arm; eventhough she received the vaccine in her left arm. One of the spots and the worst of them were a cluster of 3 puss filled pustles and a few other red spots on her right arm. I advised her to check with her primary care physician (PCP) to get a diagnosis. She returned to the pharmacy a little later with a diagnosis of shingles and  a prescription for Valacyclovir 1 Gm. Tabs. #30  Sig: Take 1 tablet by mouth 3 times daily. Dr also advised her NOT to get the 2nd dose of SHINGRIX.
Pt woke complaining of headache, body ache (particularly his arms), fatigue and severe nausea.  He did not vomit.  Sxs lasted 2 days and were followed on the 3rd day by a patchy, hive-like rash (without raised welts) on the whole upper right arm (MCV side).  No swelling.  Rash lasted 2 more days, then self resolved.
pt recvd vax;redness,swelling & pain in area where inject given on radiating neck area;ice,apap,dph given; 31mar95,mom rpts redness dec, now rash in 5" area;
Initial information received on 18-Oct-2018 regarding an unsolicited valid non-serious case received from other health professional. This case is linked to cases 2018SA291553 same reporter. This case involves a female patient of an unknown age who was received vaccine FLUZONE QUADRIVALENT (batch number, expiry date, dose, route and site of administration were unknown) on an unspecified date, while she was pregnant. The date of last menstrual period was not reported. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was actual medication error due to Expired vaccine used. It was case of vaccine exposure during pregnancy. It was reported that administered expired influenza vaccine to their employees and 1 of the employees happens to be pregnant. It was unknown whether patient experienced any adverse reaction after the injection. Pregnancy outcome was unknown at the time of report. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender- none.
no adverse effects reported; the third dose of ROTATEQ was administered to a 6-month old patient; This third dose was inadvertently administered after ROTATEQ dose was expired; This spontaneous report was received from a registered nurse referring to a 6-month-old patient of unknown gender. the patient's pertinent medical history, concurrent conditions or concomitant medications were not reported.  On 17-JUN-2019, the patient was inadvertently administered with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # R002059 (expiration date: 03-JUN-2019) third dose, orally, for prophylaxis. No adverse effects were reported.
A report received from a health care professional on 11/11/02, concerning an 80 year old female vaccinee who inadvertently received expired Fluvirin vaccine on an unknown date. The vaccinee did not experience any adverse events. There was insufficient information to determine the reporter's causality assessment. See Ref: PJP200200726.
Breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Breastfeeding) in a 19-month-old infant of an unknown gender exposed to mRNA-1273 (Moderna COVID-19 Vaccine) , while the parent received the product for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the parent received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 04-Apr-2021, the infant was diagnosed with EXPOSURE VIA BREAST MILK (Breastfeeding). At the time of the report, EXPOSURE VIA BREAST MILK (Breastfeeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.    This case was linked to MOD21-080295, MOD-2021-085949 (Parent-Child Link).   See case MOD21-080295,MOD-2021-085949 for details regarding the Parent case.  Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: No specific follow-up information recorded.
Within about one minute of receiving Gardasil I immediately started throwing up, became dizzy, covered in sweat, shaking, and felt faint. I was required to lay down for about 45 minutes and then was allowed to leave when these symptoms went away. I did not continue with the other two shots in the series.
Associate became light headed, nauseated/vomited 20 minutes after receiving flu vaccine.
Itching bumpy rash on the left side of my neck directly under my face.; This is a spontaneous report from a contactable consumer (patient). A 70-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 25Feb2021 11:00 (Batch/Lot Number: EN6200) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included asthma, polymyalgia rheumatica, vertigo, Stress Incontinence from an unknown date and unknown if ongoing. Concomitant medication included fluticasone propionate, salmeterol (WIXELA INHUB), montelukast sodium (SINGULAIR), prednisone, aciclovir sodium (ACYCLOVIR ABBOTT VIAL) taken for an unspecified indication, start and stop date were not reported. The patient previously took sulfonamide and experienced drug hypersensitivity. The patient previously took bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 02Jan2021 10:15 (Batch/Lot Number: EL3248) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient experienced itching bumpy rash on the left side of my neck directly under my face on 25Feb2021 16:00. The action taken in response to the event for bnt162b2 was not applicable. The outcome of event was not recovered.
itching; diarrhea; rash; big red spot on my arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), DIARRHOEA (diarrhea), RASH (rash) and VACCINATION SITE ERYTHEMA (big red spot on my arm) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching), DIARRHOEA (diarrhea), RASH (rash) and VACCINATION SITE ERYTHEMA (big red spot on my arm). At the time of the report, PRURITUS (itching), DIARRHOEA (diarrhea), RASH (rash) and VACCINATION SITE ERYTHEMA (big red spot on my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment information was not reported.
headache for 3 days left ear rang for 5 days (shot in left arm) both ears ring since (normal tinnitus not loud and different sound than sound after shot)
4 year old male received 3 vaccines DTaP , MMR and IPV, After 1.5 hrs post receiving the vaccines, pt returned to the clinic with a generalized red macular rash. head to toe. Received Benadryl 5 mg/kg 3.8 mg and within .5 hr symptoms resolved.
02/13/2021 at 12:00 A.m. Developed temperature 102 degrees - took OTC Tylenol and Motrin, alternating time to manage fever  02/18/2021 2am. Woke with severe chest pain, rated at 8/10, SOB, and cough. Went to ER. Admitted for possible pericarditis. Fever continues. Will be seen by cardiology and infectious disease doctors.  Patient has a history of pericarditis
Patient needed two vaccines 1st dose of Meningococcal B and 2nd dose of Menactra. Patient waited in the lobby approximately 6-8 mins while I made copies of sports physical and then they left. Patient stated had post-vaccine syncopal reaction to Men B after leaving about 20 mins later. Father brought him back in so we could re-check him. Patient stayed in clinic an additional 20mins. Vitals when he was roomed after fainting: 68/40 blood pressure, 59 heart rate and 98% oxygen level. After about 8 minutes we rechecked Vitals: 99/67, 60 heart rate, and 100% oxygen level. Patient stated he felt nervous and anxious before vaccine. Provider informed patients father to go to the emergency room to rule out possible Post-vaccination side effect of Syncope vs Seizure as father reports pt was shaking about 5-7 seconds before loss of consciousness for about 10 seconds.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent condition and medical history were not reported. On an unknown date in 2007, the patient was received with the first dose of ZOSTAVAX (strength, lot#, expiration date, dose and route were unknown), and the patient had a renal transplant in 2013, and the patient was received with the second dose of ZOSTAVAX (strength, lot#, expiration date, dose and route were unknown) on an unknown date in 2015. The outcome of renal transplant was unknown. Upon internal review, the event of renal transplant was considered to be medically significant. Additional information is not expected as there was no reporter's contact information.
chills, fever & aching all over body especially in the legs;also confused when getting up during the noc unable to find bathroom
39yo female with no documented allergies c/o being dizzy post vaccination with COVID19 Pfizer BioNTech vaccine dose #1.  No supportive treatment nor antidote given. Continued to state that she has mild pressure to her head. Ambulated without problem discharged to self.
1st vaccine 12/30/20; 2nd vaccine 1/27/21; seen at on 2/5/21 for postnasal drip, chills, cough onset x 1 day
Symptoms: Rash, low grade fever. Signs: Extensive rash covering most of body. Time course: Started on 2/27/10.
No additional AE; Nurse called and reported VARIVAX which had a temperature excursion on 06/01/2023 and was short-dated with the outcome "Supported-Within 3 months" was administered on 09/11/2023 after the three-month time period.; This spontaneous report was received from a registered nurse and refers to a patient of unknown age an gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported.  On 11-SEP-2023, the patient was vaccinated with a improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot #W031812, expiration date: 05-OCT-2024, (strength, dose, dose#, route of administration and anatomical site of vaccination were not provided) for prophylaxis (product storage error). On 01-JUN-2023, the suspect vaccine was stored at temperature from 47 to 77 Fahrenheit (F) degrees for 2 minutes.  No previous temperature excursions were reported. No additional adverse event (no adverse event).
Patient said after he arrived home his arm swelled where he received PNEUMOVAX 23 and  FLUVIRIN. Patient went to hospital and was hospitalized. Said his throat was sweeling too and chest tight.
Pt's mom states that she didn't notice any redness until the evening of the day after she received vaccine. She had large, reddened, local reaction on her thigh.
Patient came into pharmacy 12/19/2020 to report that since the vaccine administration, she has experience pain in her arm. Stiff/painful arm. She went to the MD and they told her a nerve was hit.
At 530 pm noticed hives all over body, swelling around eyes, lips, vomiting and severe stomach pain. Immediately took 50mg Benadryl by mouth and continued this dose for 2 days
My husband died of a massive pulmonary embolism four moths after receiving the vaccine on 06/24/2021 ( never had any symptoms or injuries prior to receiving the vaccine). I found my husband dead in our home upon arriving from work. An autopsy was performed and that's how I learned that he died of a massive pulmonary embolism..
Itching on Monday/ some itching on left arm; Hasn't been sleeping well; he is upset because he received SHINGRIX; Blister; Shingles today after SHINGRIX x2 in 2019/suspected vaccination failure; Today diagnosed with shingles; Injections were painful going in,dose 2; Injections were painful going in, dose 1; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis and COVID-19 VACCINE MODERNA for prophylaxis.   On 26th November 2019, the patient received the 2nd dose of Shingrix. On 22nd August 2019, the patient received the 1st dose of Shingrix. On 30th April 2022, the patient received the 4th dose of COVID-19 VACCINE MODERNA. On 22nd August 2019, immediately after receiving Shingrix, the patient experienced injection site pain. On 26th November 2019, the patient experienced injection site pain. On 5th May 2022, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the patient experienced pruritus, poor sleep, emotional distress and blister. On an unknown date, the outcome of the vaccination failure, injection site pain, injection site pain, pruritus, emotional distress and blister were unknown and the outcome of the shingles and poor sleep were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, injection site pain, pruritus, poor sleep, emotional distress and blister to be related to Shingrix. It was unknown if the reporter considered the vaccination failure, shingles, injection site pain, pruritus, poor sleep, emotional distress and blister to be related to Shingrix.     Additional Information: GSK receipt date: 05-May-2022 Reporter's comment: The patient reported that he went to his dermatologist on the day of reporting and was diagnosed with shingles after receiving both the Shingrix doses. Immediately after receiving the doses, the patient stated that the injections were painful and was going in and he paid for them, could he get a refund. More than 2 years after 1st and 2nd dose and less than a week after Moderna Covid booster dose, on Monday the patient started itching and noticed a few small blisters all down right arm and some itching on left hand. The patient also said that he has had not been sleeping well and the patient was upset because he received Shingrix doses. The reporter consented to follow-up. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding laboratory test confirming shingles were unknown at the time of reporting. It was unknown if the reporter considered the shingles, pruritus, poor sleep to be related to COVID-19 Vaccine Moderna.  Note: For Moderna Covid suspect, dose number was captured as per narrative.
11/15/05 fever, chills, diarrhea, .5 inch round raised area red and hot to touch. 11/16/05 3cm bruise 10cm red and warm to touch at area
This spontaneous report was received from a registered nurse refers to a patient of unknown age. On 01-OCT-2013, the patient was vaccinated with a dose of PROQUAD which was exposed to 50 Fahrenheit for 32 hours which was not supported. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a other refers to a patient of unknown age. On 28-JUL-2017 the patient was vaccinated with GARDASIL lot # M014929 for prophylaxis. On 28-JUL-2017, 1 day after onset of therapy the patient experienced expired product administered. On an unknown date the patient experienced no adverse event. The outcome of expired product administered and no adverse event was unknown. The reporter considered expired product administered and no adverse event to be not related to GARDASIL.
Client came in for an HPV vaccine and was accidentally given a dose of Heplisav-B. The error was immediately realized after the injection and the client was notified. She requested the HPV dose be administered. No adverse reaction was noted. I will follow-up with her tomorrow.
Myalgia Chills, body aches and pain at injection site x 3 days Narrative: Patient report pain at injection site first 3 days. Patient states on the 4th day he reported he developed chills/body aches for 1 hour then symptoms resolved.
10 days after vax, c/o severe backache and fever (high temp 101.5 deg). Backache persisted for 3 days. Saw MD on 3rd day. MD prescribed Norflex for back. Recommended Tylenol for fever. PT recovered by 4th day.